Investigator Sponsored Research

Rigel is committed to advancing the knowledge of fostamatinib and therapeutic areas of interest. Therefore, Rigel considers requests for product and/or monetary support for independent, investigator sponsored research for such scientific and medical innovation.

Please contact ISR@rigel.com for further information and instructions to apply with our Concept Submission Form.

Proposed studies will be assessed based on scientific merit, validity and rigor of the study, risk/benefit assessment to ensure the safety of human subjects, adherence to ethical guidelines concerning human subjects, consistency with Rigel’s values, and other considerations.